Alpha 2.0
Login Register
» Authors » Andrea Combalia

Andrea Combalia

Explore the profile of Andrea Combalia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 178
Followers 0
Related Specialties
Dermatology
Infectious Diseases
General Medicine
Top 10 Co-Authors
Juan Ferrando
Daniel Morgado-Carrasco
Jose M Mascaro Jr
Sebastian Podlipnik
Xavier Fusta-Novell
Ramon Grimalt
Xavier Bosch-Amate
Pilar Iranzo
Jack Green
Annika Vogt
Published In
J Dtsch Dermatol Ges
J Am Acad Dermatol
Int J Trichology
JAMA Dermatol
Indian J Dermatol Venereol Leprol
Affiliations
Soon will be listed here.
Recent Articles
1.
Study Protocol for a Prospective, Unicentric, Double-Blind, Randomized, and Placebo-Controlled Trial on the Efficacy of a Low-Histamine Diet and DAO Enzyme Supplementation in Patients with Histamine Intolerance
Duelo A, Sanchez-Perez S, Ruiz-Leon A, Casanovas-Garriga F, Pellicer-Roca S, Iduriaga-Platero I, et al.
Nutrients . 2025 Jan; 17(1. PMID: 39796463
Background/objectives: Histamine intolerance is primarily caused by a deficiency in the diamine oxidase (DAO) enzyme at the intestinal level. The reduced histamine degradation in the gut leads to its accumulation...
2.
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity
Moussa A, Bennett M, Wall D, Meah N, York K, Bokhari L, et al.
JAMA Dermatol . 2024 Feb; 160(3):341-350. PMID: 38324292
Importance: Current measures of alopecia areata (AA) severity, such as the Severity of Alopecia Tool score, do not adequately capture overall disease impact. Objective: To explore factors associated with AA...
3.
Onychomadese nach Pityriasis lichenoides et varioliformis acuta, behandelt mit Methotrexat
Corbella-Bagot L, Combalia A, Bosch-Amate X
J Dtsch Dermatol Ges . 2023 Dec; 21(12):1567-1569. PMID: 38082509
No abstract available.
4.
Onychomadesis following pityriasis lichenoides et varioliformis acuta treated with methotrexate
Corbella-Bagot L, Combalia A, Bosch-Amate X
J Dtsch Dermatol Ges . 2023 Oct; 21(12):1567-1569. PMID: 37847905
No abstract available.
5.
Rasch progrediente livid-erythematöse Knötchen bei einer älteren Frau
Gil-Lianes J, Combalia A, Estrach-Panella T
J Dtsch Dermatol Ges . 2023 Jun; 21(6):664-666. PMID: 37338852
No abstract available.
6.
Rapidly evolving violaceous nodules in an elderly woman
Gil-Lianes J, Combalia A, Estrach-Panella T
J Dtsch Dermatol Ges . 2023 May; 21(6):664-666. PMID: 37186054
No abstract available.
7.
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry
Muniesa C, Gallardo F, Garcia-Doval I, Estrach M, Combalia A, Morillo-Andujar M, et al.
J Eur Acad Dermatol Venereol . 2022 Aug; 37(1):57-64. PMID: 36017748
Background: Brentuximab vedotin (BV) has been approved for CD30-expressing cutaneous T-cell lymphoma (CTCL) after at least one previous systemic treatment. However, real clinical practice is still limited. Objectives: To evaluate...
8.
Common genetic variants associated with melanoma risk or naevus count in patients with wildtype MC1R melanoma
Calbet-Llopart N, Combalia M, Kiroglu A, Potrony M, Tell-Marti G, Combalia A, et al.
Br J Dermatol . 2022 Jun; 187(5):753-764. PMID: 35701387
Background: Hypomorphic MC1R variants are the most prevalent genetic determinants of melanoma risk in the white population. However, the genetic background of patients with wildtype (WT) MC1R melanoma is poorly...
9.
Diffuse alopecia areata induced by brentuximab vedotin therapy for advanced stage mycosis fungoides
Canal-Garcia E, Alamon-Reig F, Combalia A
Dermatol Ther . 2022 Mar; 35(5):e15427. PMID: 35262989
No abstract available.
10.
Frontal fibrosing alopecia in men: A multicenter study of 39 patients
Lobato-Berezo A, Iglesias-Sancho M, Rodriguez-Lomba E, Mir-Bonafe J, Velasco-Tamariz V, Porrino-Bustamante M, et al.
J Am Acad Dermatol . 2021 Sep; 86(2):481-484. PMID: 34562550
No abstract available.